"The aberrant expression of miR-181d-5p and cyclin-dependent kinase inhibitor 3 (CDKN3) in non-small-cell lung cancer (NSCLC) was screened by microarray analysis. There was a high expression of CDKN3 whereas miR-181d-5p was downregulated in NSCLC."xsd:string